Estrogen-lowering aromatase inhibitors are frequently prescribed to women with ovarian and uteri
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine. Contact: email@example.com
A genetic counselor discusses decision-making for people who carry BRCA1 and BRCA2 mutations
A genetic counselor discusses how genetic testing can help guide treatment decisions as well as inform preventive measures.
A genetic counselor discusses the impact of these mutations and the importance of collecting family histories.
A Rogel Cancer Center lung doctor discusses recommendations that annual screenings start at age 50 for current and former smokers with 20 “pack years”.<